L&K Biomed Ltd. (KOSDAQ: 156100)
South Korea
· Delayed Price · Currency is KRW 6,570.00
-50.00 (-0.76%)
Sep 11, 2024, 2:55 PM KST
L&K Biomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 131,782 | 202,956 | 107,379 | 143,972 | 505,923 | 73,024 | Upgrade
|
| Market Cap Growth | 108.43% | 89.01% | -25.42% | -71.54% | 592.81% | -2.93% | Upgrade
|
| Enterprise Value | 127,287 | 200,512 | 115,624 | 150,234 | 520,503 | 108,870 | Upgrade
|
| Last Close Price | 6610.00 | 10180.00 | 7212.36 | 9679.51 | 35296.46 | 6311.94 | Upgrade
|
| PE Ratio | 193.92 | -88.39 | -7.09 | -13.40 | -39.17 | -6.10 | Upgrade
|
| PS Ratio | 4.23 | 6.79 | 5.43 | 9.37 | 26.14 | 2.75 | Upgrade
|
| PB Ratio | 3.47 | 6.64 | 9.98 | 5.81 | 14.81 | 2.05 | Upgrade
|
| P/FCF Ratio | -22.07 | -59.39 | -16.06 | -13.71 | -185.94 | -126.94 | Upgrade
|
| P/OCF Ratio | -25.65 | -148.15 | -15.61 | -13.58 | -651.37 | 117133.09 | Upgrade
|
| EV/Sales Ratio | 4.17 | 6.70 | 5.85 | 9.77 | 26.89 | 4.10 | Upgrade
|
| EV/EBITDA Ratio | 58.93 | 46.12 | -11.08 | -11.08 | -675.97 | -18.74 | Upgrade
|
| EV/EBIT Ratio | 149.70 | 98.58 | -9.08 | -9.83 | -134.89 | -11.72 | Upgrade
|
| EV/FCF Ratio | -15.24 | -58.67 | -17.30 | -14.31 | -191.30 | -189.25 | Upgrade
|
| Debt / Equity Ratio | 0.74 | 0.44 | 2.34 | 0.91 | 0.59 | 0.73 | Upgrade
|
| Debt / EBITDA Ratio | 6.55 | 3.11 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | -2.84 | -3.95 | -3.77 | -2.14 | -7.35 | -45.34 | Upgrade
|
| Asset Turnover | 0.47 | 0.52 | 0.35 | 0.26 | 0.30 | 0.32 | Upgrade
|
| Inventory Turnover | 0.21 | 0.24 | 0.33 | 0.48 | 0.31 | 0.72 | Upgrade
|
| Quick Ratio | 0.96 | 1.04 | 0.50 | 1.69 | 0.58 | 0.74 | Upgrade
|
| Current Ratio | 1.64 | 1.95 | 0.95 | 3.01 | 1.63 | 1.42 | Upgrade
|
| Return on Equity (ROE) | -13.88% | -25.34% | -91.33% | -46.30% | -30.56% | -26.41% | Upgrade
|
| Return on Assets (ROA) | 1.19% | 2.20% | -14.22% | -16.15% | -3.69% | -7.09% | Upgrade
|
| Return on Capital (ROIC) | 1.68% | 3.18% | -19.14% | -18.84% | -4.16% | -8.37% | Upgrade
|
| Earnings Yield | 0.52% | -0.92% | -12.69% | -6.72% | -2.12% | -14.74% | Upgrade
|
| FCF Yield | -6.34% | -1.68% | -6.22% | -7.29% | -0.54% | -0.79% | Upgrade
|
| Buyback Yield / Dilution | -45.67% | -21.04% | -0.07% | -12.57% | -14.15% | -5.11% | Upgrade
|
| Total Shareholder Return | -45.67% | -21.04% | -0.07% | -12.57% | -14.15% | -5.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.